-
The link between the AstraZeneca vaccine and the UK’s Covid reprieve
feature Experts question claim that Oxford-developed jab has saved Britain from Europe’s high hospitalisation rates
feature -
Why under-40s will be offered alternative to Oxford-AstraZeneca vaccine
feature Experts say potential blood clot risk vs. benefits of the Covid jab is ‘more finely balanced’ for younger adults
feature -
Quiz of The Week: 3 - 9 April
Puzzles and Quizzes Have you been paying attention to The Week’s news?
Puzzles and Quizzes -
‘I’ve already had my first Oxford-AstraZeneca jab. I’ll certainly be getting my second’
Instant Opinion Your digest of analysis and commentary from the British and international press
Instant Opinion -
What Covid vaccines cost - and the countries paying over the odds
feature Figures suggest that quicker vaccine rollouts are pay to play
feature -
US health officials question AstraZeneca vaccine trial data
feature Independent monitors says the pharma giant may have used ‘out-of-date information’
feature -
Trust in Oxford-AstraZeneca vaccine collapsing across Europe, poll reveals
Speed Read More than half of people in France, Germany and Spain believe jab is unsafe
Speed Read -
Why EU countries are suspending Oxford vaccine rollouts - again
Today's Big Question Nine European nations pausing jab campaigns amid unproven blood clot fears
Today's Big Question -
Germany U-turns on Oxford-AstraZeneca vaccine
feature Berlin rolling out UK-developed jab to over-65s after doubts about efficacy disproved
feature -
EU under fire amid warnings of ‘no major breakthroughs’ on jabs
Under the Radar European leaders holding emergency meeting as calls for urgent action grow
Under the Radar -
Has ‘scaremongering’ about the Oxford jab undermined EU’s vaccination campaign?
feature People in Germany and France are refusing to be inoculated with the UK-developed vaccine
feature -
EU facing pressure to follow UK’s lead on delaying second Covid vaccine
Under the Radar World Health Organization backs decision to leave eight to 12 weeks between doses
Under the Radar -
How vaccines can be ‘tweaked’ to combat new Covid variants
feature Spread of South Africa strain of coronavirus has intensified efforts to boost jab efficacy
feature -
What does Oxford vaccine efficacy mean for getting back to normal life?
Today's Big Question New data shows jab may cut transmission by 67% - raising hopes of end to lockdowns
Today's Big Question
12